2026-05-28T09:35:54-05:00 2025-11-30 881478669 CBIZ ADVISORS LLC 1899 L STREET NW 850 WASHINGTON DC 20036 990 2024-12-01 521752473 ROSTROPOVICH-VISHNEVSKAYA FOUNDATION ROST 2022965730 1717 K STREET NW 900 WASHINGTON DC 20006 WILLIAM P AMOSS EXECUTIVE DIRECTOR 2022965730 2026-05-27 1 1 FRANK SMITH P00639053 2022274000 2026-05-27 2024 2025-03-06 01:10:19Z X WILLIAM P AMOSS 1717 K STREET NW 900 WASHINGTON DC 20006 2400004 0 X WWW.ROSTROPOVICH.ORG X 1991 DE THE ROSTROPOVICH-VISHNEVSKAYA FOUNDATION (RVF) DESIGNS AND FINANCES NATIONWIDE SUSTAINABLE HEALTHCARE INITIATIVES BENEFITING CHILDREN AND THEIR FAMILIES THROUGHOUT THE WORLD. 15 15 4 15 0 0 177076 64842 0 81900 210035 72466 0 0 387111 219208 100073 67956 0 0 788578 854902 0 10000 31813 1383403 1630914 2272054 2563772 -1884943 -2344564 3288872 1008445 71956 136093 3216916 872352 X THE ROSTROPOVICH-VISHNEVSKAYA FOUNDATION (RVF) IS A GLOBAL DEVELOPMENT ORGANIZATION THAT PROMOTES THE HEALTH AND WELLBEING OF CHILDREN IN NEED THROUGH PARTNERSHIPS THAT CREATE SUSTAINABLE, TRANSFORMATIONAL PUBLIC HEALTH PROGRAMS AROUND THE WORLD. RVF IS A NON-POLITICAL, NON-PARTISAN CHARITABLE ORGANIZATION. 0 0 2200658 RVF'S MAJOR INITIATIVE TO PROVIDE SAFE WATER FOR DRINKING AND PERSONAL HYGIENE TO CHILDREN AND THEIR FAMILIES IN GAZA WAS RESUMED IN APRIL 2024. IN 2025 RVF OPENED 9 POTABLE WATER DISTRIBUTION SITES THROUGHOUT GAZA. OF THE 18 POTABLE WATER SITES OPENED BY RVF SINCE APRIL 2024, 11 SITES REMAINED FULLY OPERATIONAL BY THE END OF 2025, DESPITE HORRIFIC WARTIME CONDITIONS. THESE SITES SERVE APPROXIMATELY 200,000 CHILDREN AND THEIR FAMILIES WITH FREE POTABLE WATER. EACH SITE IS EQUIPPED WITH A WATER DESALINATION UNIT USING REVERSE OSMOSIS AND POWERED EITHER BY A DIESEL-RUN GENERATOR OR A SOLAR POWER SYSTEM. THIS INITIATIVE IS MADE POSSIBLE BY A GENEROUS GRANT FROM THE UAE. ACCESS TO SAFE DRINKING WATER IS A GLOBAL PUBLIC HEALTH PRIORITY. IN THE GAZA STRIP, HOME TO OVER 2 MILLION PEOPLE, THERE IS AN URGENT NEED FOR POTABLE WATER TO HELP CHILDREN AND THEIR FAMILIES SURVIVE. RVF IS CONTINUING THIS LIFE-SAVING WORK IN 2026 AND INTENDS TO SCALE IT UP DRAMATICALLY. GIVEN THE SCOPE OF THE DESTRUCTION IN GAZA, COMMUNITY-BASED FIXED WATER DESALINATION SYSTEMS THROUGHOUT THE TERRITORY ARE THE MOST EFFECTIVE WAY TO PROVIDE POTABLE WATER TO THE POPULATION, AS IT WILL BE YEARS BEFORE PERMANENT INFRASTRUCTURE CAN BE REBUILT. RVF IS IN REGULAR CONTACT WITH THE GOVERNMENT OF THE UAE AND OTHER DONORS TO CONTINUE AND EXPAND THIS LIFE-SAVING WORK. 120831 67956 81900 RVF WORKS IN PARTNERSHIP WITH LOCAL GOVERNMENTS TO INTRODUCE MODERN VACCINES FOR CHILDREN INTO THE NATIONAL ROUTINE VACCINATION SCHEDULES IN MIDDLE INCOME COUNTRIES (MICS) AND PUBLISHES THE EPIDEMIOLOGICAL RESULTS OF THE PROGRAMS IN PEER-REVIEWED SCIENTIFIC JOURNALS. THE VACCINATION PROGRAMS ARE IMPLEMENTED ENTIRELY BY LOCAL HEALTH CARE WORKERS, THEREBY BUILDING LOCAL CAPACITY AND OWNERSHIP FROM THE BEGINNING, AND ARE FULLY SUSTAINED BY THE HOST GOVERNMENTS WITHIN 3 YEARS OF INCEPTION. FOLLOWING THE LAUNCH OF THE RVF-INITIATED ROTAVIRUS VACCINATION PROGRAM FOR ALL INFANTS IN GAZA AND THE WEST BANK IN 2016- APPROXIMATELY 135,000 BABIES ANNUALLY RVF, WITH FINANCING FROM THE BILL & MELINDA GATES FOUNDATION, HAS BEEN CONDUCTING SURVEILLANCE DOCUMENTING THE IMPACT OF THE ROTAVIRUS VACCINE ON THE DISEASE BURDEN. THE RESULTS OF THE FIRST PHASE OF THE SURVEILLANCE WERE PUBLISHED IN THE PEER-REVIEWED JOURNAL VACCINE. UNFORTUNATELY, DUE TO THE WAR, THE SUPPLY OF ROTAVIRUS VACCINE WAS INTERRUPTED FROM JUNE THROUGH DECEMBER 2024, SO THERE IS A POSSIBILITY THAT ROTAVIRUS DISEASE WILL REEMEERGE BEFORE THE VACCINE SUPPLY CAN BE REPLENISHED AND VACCINATION RESUME IN 2025. IN EGYPT RVF CONTIUNES ITS INITIATIVE TO INTRODUCE THE ROTAVIRUS VACCINE INTO THE NATIONAL IMMUNIZATION SCHEDULE FOR CHILDREN AND TO TRANSFER THE TECHNOLOGY TO MANUFACTURE THE VACCINE IN THE COUNTRY. THE RVF-SPONSORED BASELINE STUDY OF ROTAVIRUS DISEASE PREVALENCE IN EGYPT, FINANCED BY THE GATES FOUNDATION AND PUBLISHED IN THE EGYPTIAN PHARMACEUTICAL JOURNAL, HAS LENT MOMENTUM TO THE REGISTRATION PROCESS OF THE VACCINE IN EGYPT AND THE PLANNING OF THE TECH TRANSFER FROM THE INDIAN MANUFACTURER TO AN EGYPTIAN VACCINE MANUFACTURER. 2321489 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 2 0 1 4 1 0 1 GG RS OC 0 0 0 0 0 0 0 0 0 0 X 15 15 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 X X MERLE NILK 2022965730 1717 K STREET NW 900 WASHINGTON DC 20006 ELENA ROSTROPOVICH PRESIDENT 3.00 X X 0 0 0 THOMAS R PICKERING CHAIRMAN 3.00 X X 0 0 0 CATHERINE MANNICK SECRETARY/TREASURER UNTIL 11/25 3.00 X X 0 0 0 STANLEY PLOTKIN MD CHAIRMAN EMERITUS 1.00 X 0 0 0 RAZAN AL SHATTI DIRECTOR 1.00 X 0 0 0 EDWIN ASTURIAS DIRECTOR 1.00 X 0 0 0 JOHN BEYRLE DIRECTOR 1.00 X 0 0 0 CONSUELO DUROC-DANNER DIRECTOR 1.00 X 0 0 0 MONIQUE DUROC-DANNER DIRECTOR 1.00 X 0 0 0 NANCY ELY-RAPHEL DIRECTOR AS OF 6/25 1.00 X 0 0 0 LUBNA HUSSAIN DIRECTOR 1.00 X 0 0 0 NATASHA LEBEDEVA DIRECTOR 1.00 X 0 0 0 J STEPHEN MORRISON DIRECTOR 1.00 X 0 0 0 GHASSAN MUSTAKLEM DIRECTOR 1.00 X 0 0 0 KIMBERLY A NEARING DIRECTOR 1.00 X 0 0 0 WILLIAM P AMOSS EXECUTIVE DIRECTOR 40.00 X 200000 0 6000 MERLE NILK FINANCE DIRECTOR 40.00 X 150000 0 4500 350000 0 10500 2 0 1 0 0 64842 18000 64842 SERVICE FEES 900099 81900 81900 81900 85315 85315 2167947 2180796 -12849 -12849 -12849 219208 81900 0 72466 67956 67956 408297 367467 21492 19338 356051 338320 17289 442 4442 4418 24 44813 38395 4385 2033 41299 38330 2969 29999 20000 9999 38551 32571 5980 10000 10000 175 175 117440 116634 806 58858 7475 51383 68220 34110 34110 83716 28704 55012 2130 1447 683 6163 6163 PROGRAM MATERIALS & SVC 1225662 1225662 2563772 2321489 210470 31813 170176 76657 2878176 782990 32775 9730 5000 32531 29479 2299 3052 6791 221700 107971 3288872 1008445 71956 39771 0 96322 71956 136093 X 491639 382028 2725277 490324 3216916 872352 3288872 1008445 -2344564 0 X 0 1 X 1 0 X 902374 6333793 1113541 177076 64842 8591626 902374 6333793 1113541 177076 64842 8591626 1749419 6842207 185 10603 48605 190527 85315 335235 3016 3016 8929877 519230 0.76620 0.73020 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2020 AMOUNT: $ 3,016. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 32531 29479 3052 3052 DEPOSITS 11649 RIGHT OF USE ASSET 96322 107971 LEASE LIABILITIES 96322 96322 X 238833 19800 19800 219033 175 175 219208 2583397 19800 19800 2563597 175 175 2563772 PART X, LINE 2: THE FOUNDATION EVALUATED ITS UNCERTAINTY IN INCOME TAXES FOR THE YEAR ENDED NOVEMBER 30, 2025, AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. 1 MIDDLE EAST AND NORTH AFRICA 1 3 PROGRAM SERVICES VACCINATION & WATER PROJECT 1468119 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING 67956 MIDDLE EAST AND NORTH AFRICA 0 1 FUNDRAISING 10000 1 4 0 0 1 4 1546075 0 1546075 MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, STUDY 34186 WIRE TRANSFER 0 MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, STUDY 33770 WIRE TRANSFER 0 2 0 0 0 0 0 0 0 PART I, LINE 2: RVF HAS AN AGREEMENT WITH THE ENTITY IT GRANTS THE FUNDS. THE ENTITY HAS TO PROVIDE QUARTERLY REPORTS FOR THE ADVANCED FUNDS. THE NEXT TRANCHE OF FUNDS WILL BE ADVANCED ONCE THE PREVIOUS AMOUNT IS USED AND THE REPORT IS APPROVED BY RVF. PART I, LINE 3: RVF REPORTED THE EXPENDITURES BASED ON THE ACCOUNTING METHOD USED IN ITS AUDITED FINANCIAL STATEMENTS WHICH IS ON AN ACCRUAL BASIS. X 0 0 0 0 0 0 0 0 0 WILLIAM P AMOSS EXECUTIVE DIRECTOR 200000 0 0 0 0 0 23368 0 0 0 223368 0 0 0 MERLE NILK FINANCE DIRECTOR 150000 0 0 0 0 0 11153 0 0 0 161153 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B INFORMATION TO COMPLETE THE FEDERAL FORM 990 IS GATHERED BY THE FINANCE DIRECTOR AND PROVIDED TO RVF'S PUBLIC ACCOUNTING FIRM FOR PREPARATION. THE FINANCE DIRECTOR AND THE EXECUTIVE DIRECTOR REVIEW THE RETURN AND REQUEST ANY CHANGES, IF NECESSARY, FROM THE RVF'S PUBLIC ACCOUNTING FIRM. ONCE THE FEDERAL FORM 990 HAS BEEN REVIEWED AND CORRECTED AS NEEDED, IT IS DISTRIBUTED TO ALL CURRENT BOARD MEMBERS, REQUESTING THEY REVIEW THE FEDERAL FORM 990 PRIOR TO FILING. THE BOARD MEMBERS ARE ASKED TO REVIEW AND ARE GIVEN AN OPPORTUNITY TO RAISE ISSUES AND REQUEST CLARIFICATIONS. ONCE THIS PROCESS IS COMPLETE, THE FEDERAL FORM 990 IS FILED. FORM 990, PART VI, SECTION B, LINE 12C RVF COMPLIES WITH THE INTERNAL REVENUE SERVICE'S SUGGESTED BEST PRACTICES REGARDING CONFLICT OF INTEREST POLICIES APPLICABLE TO NONPROFIT AND CHARITABLE ORGANIZATIONS. UNDER RVF'S CONFLICT OF INTEREST POLICY, OFFICERS, DIRECTORS AND ALL EMPLOYEES ARE REQUIRED TO SIGN A CONFLICT OF INTEREST DISCLOSURE STATEMENT ANNUALLY. THE SIGNED DISCLOSURE STATEMENTS ARE REVIEWED BY AND HELD BY THE ADMINISTRATOR. THE POLICY APPLIES TO ALL OFFICERS, DIRECTORS AND EMPLOYEES. IT DEFINES AREAS OF POTENTIAL CONFLICT, THE PROCESSES FOR INDEPENDENT REVIEW AND RESOLUTION OF POTENTIAL CONFLICTS, AND THE ACTIONS REQUIRED IN THE EVENT OF NON-COMPLIANCE. IN CASES WHERE THE BOARD, A COMMITTEE THEREOF, THE PRESIDENT OR A SUPERVISOR HAS REASONABLE CAUSE TO BELIEVE AN INDIVIDUAL HAS FAILED TO COMPLY WITH THE POLICY, THE INDIVIDUAL IS PROVIDED AN OPPORTUNITY TO EXPLAIN THE ALLEGED VIOLATION. VIOLATORS ARE SUBJECT TO DISCIPLINARY AND CORRECTIVE ACTION. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION OF OFFICERS AND KEY EMPLOYEES IS REVIEWED AT THE FINANCE AND AUDIT COMMITTEE MEETING. THIS COMMITTEE APPROVES COMPENSATION, BUT IF ANY CONCERNS ARISE, THEY MAY REVIEW IT WITH THE ENTIRE BOARD OF DIRECTORS. THE DISCUSSION AND DECISION IS RECORDED IN THE MEETING MINUTES. THE FINANCE & AUDIT COMMITTEE CONDUCTED THE COMPENSATION REVIEW IN JANUARY 2023. FORM 990, PART VI, SECTION C, LINE 19 RVF'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, FEDERAL FORM 1023 AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE FEDERAL FORM 990 IS AVAILABLE TO THE PUBLIC ON OUR WEBSITE. THESE DOCUMENTS ARE ALWAYS SUBMITTED IN APPLICATION PACKAGES FOR FUNDING REQUESTS. ROSTROPOVICH-VISHNEVSKAYA FOUNDATION GEORGIA 3 R ERISTAVI STREET TBILISI GG 00179 CHARITABLE ACTIVITIES IN THE AREA OF HEALTH CARE GG RVF (US) 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0